首页> 外文OA文献 >A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy

【2h】

A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy

机译：一种双盲随机比较临床试验，以评估用WT1肽（TLP0-001）的树突状细胞疫苗的安全性和有效性与S-1组合在患有先进的胰腺癌难治度到标准化疗的患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Masahiro Katsuda; Motoki Miyazawa; Toshiyasu Ojima; Akio Katanuma; Kenichi Hakamada; Kentaro Sudo; Shingo Asahara; Itaru Endo; Makoto Ueno; Kazuo Hara; Suguru Yamada; Tsutomu Fujii; Sohei Satoi; Tatsuya Ioka; Masaichi Ohira; Takahiro Akahori; Masayuki Kitano; Hiroaki Nagano; Masayuki Furukawa; Tomohiko Adachi; Hiroki Yamaue;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy [J] . Masahiro Katsuda, Motoki Miyazawa, Toshiyasu Ojima, Trials . 2019,第1期

机译：一种双盲随机比较临床试验，以评估用WT1肽（TLP0-001）的树突状细胞疫苗的安全性和有效性与S-1组合在患有先进的胰腺癌难治度到标准化疗的患者
2. 53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin?) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva?) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer [J] . R.Herbst, V.ONeill, L.Fehrenbacher, European Journal of Cancer Supplements . 2006,第12期

机译：53 POSTER A II期，多中心，随机临床试验，评估贝伐单抗（Avastin？）联合化疗（多西他赛或培美曲塞）或盐酸厄洛替尼（Tarceva？）与单纯化疗联合治疗复发或难治性的疗效和安全性非小细胞肺癌
3. Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer [J] . Rong Xu, Nan Ma, Fang Wang, OncoTargets and therapy . 2013,第4期

机译：评估Endostar和S-1联合奥沙利铂联合治疗晚期胃癌的有效性和安全性的随机对照临床试验结果
4. A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy [O] . Masahiro Katsuda, Motoki Miyazawa, Toshiyasu Ojima, 2019

机译：评估WT1肽（TLP0-001）结合S-1的树突状细胞疫苗在标准化疗难治性晚期胰腺癌患者中的安全性和有效性的双盲随机对照临床试验
5. A Double-blind Randomized Comparative Clinical Trial to Evaluate the Safety and Efficacy of Dendritic Cell Vaccine Loaded with WT1 Peptides (TLP0-001) in Combination with S-1 in Patients with Advanced Pancreatic Cancer Refractory to Standard Chemotherapy [O] . Masahiro Katsuda, Motoki Miyazawa, Toshiyasu Ojima, 2019

机译：一种双盲随机比较临床试验，以评估用WT1肽（TLP0-001）的树突状细胞疫苗的安全性和有效性与S-1组合在患有先进的胰腺癌难治度到标准化疗的患者

A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅